Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abortion, Induced | 15 | 2023 | 462 | 1.490 |
Why?
|
Asthma, Aspirin-Induced | 6 | 2024 | 202 | 0.980 |
Why?
|
Misoprostol | 5 | 2022 | 93 | 0.650 |
Why?
|
Abortifacient Agents, Nonsteroidal | 5 | 2022 | 64 | 0.590 |
Why?
|
Sinusitis | 4 | 2024 | 990 | 0.430 |
Why?
|
Intrauterine Devices | 4 | 2016 | 113 | 0.410 |
Why?
|
Voice | 5 | 2015 | 268 | 0.360 |
Why?
|
Mifepristone | 3 | 2016 | 151 | 0.360 |
Why?
|
Pancreatitis, Acute Necrotizing | 5 | 2010 | 171 | 0.350 |
Why?
|
Rhinitis | 3 | 2023 | 747 | 0.340 |
Why?
|
Lung Diseases, Interstitial | 3 | 2023 | 918 | 0.330 |
Why?
|
Chorionic Gonadotropin | 3 | 2016 | 457 | 0.310 |
Why?
|
Nasal Polyps | 2 | 2023 | 395 | 0.280 |
Why?
|
Intrauterine Devices, Copper | 2 | 2019 | 30 | 0.280 |
Why?
|
Lymphangioleiomyomatosis | 2 | 2020 | 204 | 0.270 |
Why?
|
Vocal Cords | 3 | 2016 | 520 | 0.260 |
Why?
|
Contraception | 3 | 2020 | 347 | 0.250 |
Why?
|
Speech Acoustics | 3 | 2015 | 154 | 0.240 |
Why?
|
Carbon Monoxide | 2 | 2018 | 547 | 0.240 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2022 | 514 | 0.230 |
Why?
|
Eustachian Tube | 1 | 2024 | 99 | 0.220 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3753 | 0.210 |
Why?
|
Ear Diseases | 1 | 2024 | 181 | 0.210 |
Why?
|
Analgesia, Obstetrical | 1 | 2023 | 169 | 0.190 |
Why?
|
Lacerations | 1 | 2022 | 147 | 0.180 |
Why?
|
Pancreatitis | 3 | 2011 | 1081 | 0.180 |
Why?
|
Analgesia, Epidural | 1 | 2023 | 332 | 0.170 |
Why?
|
Severity of Illness Index | 10 | 2014 | 15841 | 0.170 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2019 | 26 | 0.160 |
Why?
|
Administration, Inhalation | 2 | 2018 | 1159 | 0.160 |
Why?
|
Respiratory Therapy | 1 | 2018 | 125 | 0.150 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2020 | 321 | 0.150 |
Why?
|
Larynx | 2 | 2014 | 492 | 0.150 |
Why?
|
Anesthetics, Intravenous | 2 | 2018 | 394 | 0.150 |
Why?
|
Respiratory Tract Diseases | 1 | 2023 | 748 | 0.140 |
Why?
|
Drug Dosage Calculations | 1 | 2018 | 117 | 0.140 |
Why?
|
Pregnancy Trimester, Second | 3 | 2022 | 732 | 0.140 |
Why?
|
Gynecology | 2 | 2013 | 528 | 0.140 |
Why?
|
Gastroesophageal Reflux | 4 | 2008 | 821 | 0.140 |
Why?
|
Respiratory Tract Infections | 2 | 2016 | 1009 | 0.140 |
Why?
|
Allied Health Personnel | 1 | 2018 | 154 | 0.140 |
Why?
|
Sound Spectrography | 2 | 2015 | 113 | 0.140 |
Why?
|
Aspirin | 6 | 2024 | 3129 | 0.130 |
Why?
|
Naproxen | 1 | 2016 | 100 | 0.130 |
Why?
|
Female | 62 | 2024 | 392544 | 0.130 |
Why?
|
Conscious Sedation | 2 | 2018 | 533 | 0.130 |
Why?
|
Obstetrics | 2 | 2013 | 668 | 0.130 |
Why?
|
Vacuum Curettage | 2 | 2018 | 44 | 0.130 |
Why?
|
Pregnancy | 16 | 2023 | 29893 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2023 | 2270 | 0.130 |
Why?
|
Dilatation and Curettage | 1 | 2015 | 52 | 0.130 |
Why?
|
Fundoplication | 2 | 2007 | 144 | 0.130 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2015 | 284 | 0.130 |
Why?
|
Outpatients | 1 | 2023 | 1598 | 0.130 |
Why?
|
Professional Role | 1 | 2018 | 313 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2019 | 4014 | 0.120 |
Why?
|
Esophagoscopy | 2 | 2007 | 398 | 0.120 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2014 | 108 | 0.120 |
Why?
|
Voice Quality | 2 | 2013 | 225 | 0.110 |
Why?
|
Esophagogastric Junction | 2 | 2007 | 347 | 0.110 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2014 | 105 | 0.110 |
Why?
|
Automobile Driving | 1 | 2019 | 441 | 0.110 |
Why?
|
Adult | 41 | 2024 | 221119 | 0.110 |
Why?
|
Labor Stage, First | 1 | 2013 | 20 | 0.110 |
Why?
|
Liver Cirrhosis | 3 | 2009 | 1932 | 0.110 |
Why?
|
Humans | 72 | 2024 | 761208 | 0.110 |
Why?
|
Prospective Studies | 20 | 2024 | 54435 | 0.110 |
Why?
|
Thyroid Gland | 1 | 2019 | 1169 | 0.100 |
Why?
|
Hydroxychloroquine | 1 | 2017 | 426 | 0.100 |
Why?
|
Biological Products | 1 | 2022 | 915 | 0.100 |
Why?
|
Pain | 4 | 2023 | 5072 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 8 | 2016 | 20588 | 0.100 |
Why?
|
Thyroid Nodule | 1 | 2019 | 763 | 0.100 |
Why?
|
Tomography, Optical Coherence | 2 | 2016 | 2923 | 0.100 |
Why?
|
Quality of Life | 7 | 2024 | 13367 | 0.100 |
Why?
|
Social Stigma | 1 | 2018 | 770 | 0.100 |
Why?
|
Sputum | 1 | 2014 | 505 | 0.100 |
Why?
|
Headache | 2 | 2017 | 1255 | 0.100 |
Why?
|
Nerve Fibers | 1 | 2014 | 707 | 0.090 |
Why?
|
Obstetric Labor Complications | 1 | 2013 | 236 | 0.090 |
Why?
|
Antiemetics | 1 | 2012 | 186 | 0.090 |
Why?
|
Cicatrix | 1 | 2016 | 793 | 0.090 |
Why?
|
Mucous Membrane | 1 | 2013 | 659 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 825 | 0.090 |
Why?
|
Physicians | 2 | 2019 | 4584 | 0.080 |
Why?
|
Esophageal pH Monitoring | 2 | 2008 | 203 | 0.080 |
Why?
|
Sirolimus | 1 | 2017 | 1540 | 0.080 |
Why?
|
Databases, Factual | 3 | 2015 | 7966 | 0.080 |
Why?
|
Labor, Induced | 1 | 2011 | 152 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2017 | 4190 | 0.080 |
Why?
|
Tonsillectomy | 1 | 2012 | 277 | 0.080 |
Why?
|
Fetal Death | 1 | 2011 | 435 | 0.080 |
Why?
|
Middle Aged | 30 | 2024 | 220853 | 0.080 |
Why?
|
Hematocrit | 1 | 2010 | 623 | 0.080 |
Why?
|
Congenital Abnormalities | 1 | 2014 | 707 | 0.080 |
Why?
|
Pregnancy Trimester, First | 3 | 2018 | 908 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2012 | 416 | 0.080 |
Why?
|
Young Adult | 15 | 2019 | 59221 | 0.080 |
Why?
|
Retinal Ganglion Cells | 1 | 2014 | 810 | 0.080 |
Why?
|
Nurses | 1 | 2018 | 2477 | 0.080 |
Why?
|
Leukopenia | 1 | 2009 | 213 | 0.080 |
Why?
|
Speech Perception | 1 | 2013 | 508 | 0.080 |
Why?
|
Male | 38 | 2024 | 360693 | 0.080 |
Why?
|
Double-Blind Method | 6 | 2022 | 12341 | 0.080 |
Why?
|
Carboxyhemoglobin | 2 | 2018 | 83 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2317 | 0.070 |
Why?
|
Collagen | 1 | 2016 | 2635 | 0.070 |
Why?
|
Hepatic Veins | 1 | 2008 | 112 | 0.070 |
Why?
|
Cystic Fibrosis | 2 | 2014 | 1283 | 0.070 |
Why?
|
Chronic Disease | 4 | 2024 | 9319 | 0.070 |
Why?
|
Attitude to Health | 1 | 2016 | 2026 | 0.070 |
Why?
|
Helium | 1 | 2007 | 119 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2193 | 0.070 |
Why?
|
Desensitization, Immunologic | 2 | 2023 | 557 | 0.070 |
Why?
|
Gastrointestinal Motility | 1 | 2008 | 233 | 0.070 |
Why?
|
Treatment Outcome | 15 | 2024 | 64681 | 0.070 |
Why?
|
Aftercare | 1 | 2013 | 913 | 0.070 |
Why?
|
Ultrasonography | 3 | 2019 | 5969 | 0.070 |
Why?
|
Speech | 1 | 2011 | 554 | 0.070 |
Why?
|
Thioguanine | 1 | 2006 | 45 | 0.070 |
Why?
|
Clinical Clerkship | 1 | 2012 | 564 | 0.070 |
Why?
|
Dyspnea | 1 | 2014 | 1347 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 1272 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3885 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3702 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2330 | 0.070 |
Why?
|
Hysterectomy | 1 | 2011 | 857 | 0.070 |
Why?
|
Fetus | 1 | 2013 | 1864 | 0.060 |
Why?
|
Midazolam | 2 | 2018 | 267 | 0.060 |
Why?
|
Artifacts | 1 | 2014 | 1912 | 0.060 |
Why?
|
Cesarean Section | 1 | 2014 | 1399 | 0.060 |
Why?
|
Hoarseness | 1 | 2006 | 63 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2164 | 0.060 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2006 | 90 | 0.060 |
Why?
|
Nutritional Support | 1 | 2007 | 173 | 0.060 |
Why?
|
Age Factors | 4 | 2015 | 18384 | 0.060 |
Why?
|
Esophageal and Gastric Varices | 1 | 2008 | 208 | 0.060 |
Why?
|
Catheters, Indwelling | 1 | 2008 | 426 | 0.060 |
Why?
|
Mesalamine | 1 | 2006 | 134 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3564 | 0.060 |
Why?
|
Platelet Count | 1 | 2008 | 782 | 0.060 |
Why?
|
Dexamethasone | 1 | 2012 | 1945 | 0.060 |
Why?
|
Glaucoma | 1 | 2014 | 1186 | 0.060 |
Why?
|
Diet, Fat-Restricted | 1 | 2007 | 329 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1116 | 0.060 |
Why?
|
Postpartum Period | 1 | 2011 | 1178 | 0.060 |
Why?
|
Perioperative Care | 1 | 2012 | 1037 | 0.060 |
Why?
|
Adolescent | 14 | 2019 | 88298 | 0.060 |
Why?
|
Pregnancy Outcome | 1 | 2015 | 2923 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2585 | 0.060 |
Why?
|
Azathioprine | 1 | 2006 | 354 | 0.060 |
Why?
|
Fentanyl | 2 | 2018 | 433 | 0.060 |
Why?
|
Catheterization, Peripheral | 1 | 2008 | 343 | 0.060 |
Why?
|
Suture Techniques | 2 | 2007 | 768 | 0.060 |
Why?
|
Vital Capacity | 2 | 2017 | 970 | 0.060 |
Why?
|
Palliative Care | 1 | 2019 | 3599 | 0.060 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2009 | 619 | 0.060 |
Why?
|
Laryngoscopy | 3 | 2014 | 707 | 0.060 |
Why?
|
ROC Curve | 4 | 2014 | 3584 | 0.060 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 934 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2035 | 0.050 |
Why?
|
Retrospective Studies | 13 | 2022 | 80674 | 0.050 |
Why?
|
Patient Transfer | 1 | 2010 | 794 | 0.050 |
Why?
|
Body Mass Index | 2 | 2018 | 12952 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2007 | 927 | 0.050 |
Why?
|
Esophagus | 1 | 2008 | 1036 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1157 | 0.050 |
Why?
|
Massachusetts | 3 | 2020 | 8837 | 0.050 |
Why?
|
Forced Expiratory Volume | 2 | 2017 | 1813 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3534 | 0.050 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2254 | 0.050 |
Why?
|
Reference Values | 3 | 2015 | 4921 | 0.050 |
Why?
|
Cough | 1 | 2006 | 594 | 0.050 |
Why?
|
Contrast Media | 2 | 2012 | 5311 | 0.050 |
Why?
|
Asthma | 1 | 2020 | 6230 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1616 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14610 | 0.050 |
Why?
|
APACHE | 2 | 2011 | 267 | 0.050 |
Why?
|
Cross-Sectional Studies | 7 | 2019 | 26071 | 0.050 |
Why?
|
Pain Measurement | 3 | 2018 | 3549 | 0.050 |
Why?
|
Dilatation | 1 | 2022 | 307 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 398 | 0.050 |
Why?
|
Thrombocytopenia | 1 | 2009 | 1182 | 0.050 |
Why?
|
Aged | 16 | 2024 | 169288 | 0.050 |
Why?
|
Gestational Age | 2 | 2023 | 3580 | 0.050 |
Why?
|
Clinical Competence | 2 | 2013 | 4788 | 0.050 |
Why?
|
Apolipoproteins E | 1 | 2006 | 1443 | 0.040 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1122 | 0.040 |
Why?
|
Child, Preschool | 8 | 2015 | 42224 | 0.040 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2007 | 876 | 0.040 |
Why?
|
DNA | 1 | 2014 | 7189 | 0.040 |
Why?
|
Eicosanoids | 1 | 2022 | 282 | 0.040 |
Why?
|
Parity | 1 | 2023 | 929 | 0.040 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1212 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4678 | 0.040 |
Why?
|
Anemia | 1 | 2009 | 1504 | 0.040 |
Why?
|
Dietary Fats | 1 | 2007 | 1994 | 0.040 |
Why?
|
Students, Medical | 1 | 2012 | 1940 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20119 | 0.040 |
Why?
|
Capsule Endoscopy | 2 | 2012 | 102 | 0.040 |
Why?
|
Levonorgestrel | 1 | 2019 | 74 | 0.040 |
Why?
|
Algorithms | 3 | 2018 | 14025 | 0.040 |
Why?
|
Chest Pain | 1 | 2006 | 1097 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2007 | 2513 | 0.040 |
Why?
|
Vietnam | 1 | 2019 | 406 | 0.040 |
Why?
|
Time Factors | 6 | 2016 | 39957 | 0.040 |
Why?
|
Depersonalization | 1 | 2018 | 39 | 0.040 |
Why?
|
Swine | 3 | 2016 | 5909 | 0.040 |
Why?
|
Family Planning Services | 1 | 2021 | 267 | 0.040 |
Why?
|
Cohort Studies | 7 | 2022 | 41496 | 0.040 |
Why?
|
Child | 10 | 2017 | 80152 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7407 | 0.040 |
Why?
|
Exercise | 1 | 2014 | 5874 | 0.040 |
Why?
|
Risk Assessment | 6 | 2019 | 24021 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 2018 | 379 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 809 | 0.040 |
Why?
|
Pilot Projects | 3 | 2018 | 8642 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2017 | 63 | 0.040 |
Why?
|
Self-Assessment | 1 | 2019 | 399 | 0.030 |
Why?
|
Survival Analysis | 3 | 2016 | 10088 | 0.030 |
Why?
|
Administration, Intravaginal | 1 | 2016 | 149 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6505 | 0.030 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39126 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2023 | 941 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2018 | 392 | 0.030 |
Why?
|
Mucositis | 1 | 2017 | 108 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3418 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2009 | 506 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 1685 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1751 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11476 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12939 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1118 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9616 | 0.030 |
Why?
|
Postoperative Period | 2 | 2011 | 1818 | 0.030 |
Why?
|
Voice Training | 1 | 2014 | 44 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1577 | 0.030 |
Why?
|
Tissue Embedding | 1 | 2013 | 42 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2018 | 3453 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2014 | 510 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2019 | 816 | 0.030 |
Why?
|
Prevalence | 3 | 2019 | 15721 | 0.030 |
Why?
|
Phonation | 1 | 2015 | 220 | 0.030 |
Why?
|
Risk-Taking | 1 | 2019 | 1038 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 865 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58952 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5885 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2015 | 383 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2217 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2014 | 410 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2013 | 280 | 0.030 |
Why?
|
Spouses | 1 | 2014 | 284 | 0.020 |
Why?
|
Liver | 1 | 2008 | 7514 | 0.020 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2012 | 128 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 614 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2006 | 2421 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2011 | 224 | 0.020 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 342 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2012 | 573 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7226 | 0.020 |
Why?
|
Dysphonia | 1 | 2013 | 144 | 0.020 |
Why?
|
Sex Factors | 2 | 2015 | 10553 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8998 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2006 | 3406 | 0.020 |
Why?
|
United States | 5 | 2019 | 72339 | 0.020 |
Why?
|
Diarrhea | 1 | 2017 | 1316 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1668 | 0.020 |
Why?
|
Voice Disorders | 1 | 2013 | 284 | 0.020 |
Why?
|
Uganda | 1 | 2014 | 1332 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3803 | 0.020 |
Why?
|
Burnout, Professional | 1 | 2018 | 703 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2012 | 958 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27092 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2013 | 514 | 0.020 |
Why?
|
Incidence | 3 | 2016 | 21365 | 0.020 |
Why?
|
Organ Size | 1 | 2014 | 2253 | 0.020 |
Why?
|
Risk Factors | 5 | 2019 | 74239 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1327 | 0.020 |
Why?
|
Multiple Organ Failure | 1 | 2011 | 386 | 0.020 |
Why?
|
Lung | 1 | 2007 | 9979 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3840 | 0.020 |
Why?
|
Intraocular Pressure | 1 | 2014 | 1294 | 0.020 |
Why?
|
Auditory Perception | 1 | 2013 | 584 | 0.020 |
Why?
|
Pregnancy Rate | 1 | 2011 | 648 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4015 | 0.020 |
Why?
|
Venous Pressure | 1 | 2008 | 55 | 0.020 |
Why?
|
Esophagitis, Peptic | 1 | 2008 | 76 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1624 | 0.020 |
Why?
|
Portal Pressure | 1 | 2008 | 60 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2014 | 909 | 0.020 |
Why?
|
Visual Fields | 1 | 2014 | 1059 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3251 | 0.020 |
Why?
|
Isotopes | 1 | 2007 | 125 | 0.020 |
Why?
|
Education, Medical | 1 | 2019 | 1725 | 0.020 |
Why?
|
Infant | 3 | 2014 | 36169 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14675 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2610 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2011 | 36415 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1186 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2241 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2011 | 970 | 0.020 |
Why?
|
Laser Therapy | 1 | 2013 | 1094 | 0.020 |
Why?
|
Length of Stay | 2 | 2011 | 6417 | 0.020 |
Why?
|
Computer Graphics | 1 | 2007 | 338 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2016 | 2770 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4851 | 0.020 |
Why?
|
Hypertrophy | 1 | 2007 | 558 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3590 | 0.020 |
Why?
|
Visual Acuity | 1 | 2014 | 2676 | 0.020 |
Why?
|
Swine, Miniature | 1 | 2007 | 961 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 2007 | 651 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 3512 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13249 | 0.010 |
Why?
|
Monitoring, Ambulatory | 1 | 2007 | 355 | 0.010 |
Why?
|
Data Collection | 1 | 2013 | 3320 | 0.010 |
Why?
|
Patient Admission | 1 | 2011 | 1365 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2019 | 4487 | 0.010 |
Why?
|
Animals | 6 | 2016 | 168079 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15308 | 0.010 |
Why?
|
Bronchi | 1 | 2007 | 843 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8519 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5493 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3805 | 0.010 |
Why?
|
Endosonography | 1 | 2007 | 608 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2016 | 18220 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 877 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6819 | 0.010 |
Why?
|
Reoperation | 1 | 2013 | 4303 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2011 | 22174 | 0.010 |
Why?
|
Caregivers | 1 | 2014 | 2244 | 0.010 |
Why?
|
Lipoproteins | 1 | 2006 | 877 | 0.010 |
Why?
|
Homozygote | 1 | 2006 | 1775 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12474 | 0.010 |
Why?
|
Trachea | 1 | 2007 | 1090 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10756 | 0.010 |
Why?
|
Pain, Postoperative | 1 | 2011 | 1741 | 0.010 |
Why?
|
Remission Induction | 1 | 2006 | 2392 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11067 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10218 | 0.010 |
Why?
|
Blotting, Western | 1 | 2006 | 5032 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14392 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11119 | 0.010 |
Why?
|
Prognosis | 2 | 2009 | 29687 | 0.010 |
Why?
|
Cholesterol | 1 | 2006 | 2902 | 0.010 |
Why?
|
Comorbidity | 1 | 2011 | 10516 | 0.010 |
Why?
|
Image Enhancement | 1 | 2007 | 2888 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6781 | 0.010 |
Why?
|
Mice | 3 | 2014 | 81326 | 0.010 |
Why?
|
Lipids | 1 | 2006 | 3331 | 0.010 |
Why?
|
Patient Discharge | 1 | 2008 | 3441 | 0.010 |
Why?
|
Survival Rate | 1 | 2009 | 12728 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1991 | 7851 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9520 | 0.010 |
Why?
|
Patient Readmission | 1 | 2008 | 3265 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12976 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2014 | 26199 | 0.010 |
Why?
|
Macrophages | 1 | 2006 | 5753 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9457 | 0.010 |
Why?
|
Chloride Channels | 1 | 1991 | 221 | 0.010 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1991 | 450 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22127 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1991 | 1988 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17897 | 0.000 |
Why?
|
Protein Kinases | 1 | 1991 | 1607 | 0.000 |
Why?
|